Surgery after drug therapy for advanced bladder cancer that has spread to a few spots
Part of Cancer, Kidney & urinary clinical trials.
This study tests whether adding surgery to remove the original bladder tumor and any remaining cancer spots can help people with advanced bladder cancer that has spread to only a few areas. It is for people who have already started a specific type of chemotherapy and whose cancer has not grown.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are able to care for yourself and be up and about (ECOG 0 or 1).
- You are healthy enough to have surgery on your bladder and possibly on the cancer spots that have spread.
- Your cancer is a type called urothelial carcinoma (bladder cancer) that has spread to 5 or fewer spots.
- You have been on a drug called enfortumab vedotin for at least 3 months, and your latest scan shows the cancer is stable, shrank, or disappeared.
- You do not have cancer in the brain or spinal fluid.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a tiny device placed into bladder tumors before surgery to see which drugs might work best for each patient, helping guide future treatment choices.
This Phase 2 study tests giving standard chemotherapy first, then immunotherapy, followed by major surgery to remove the bladder/urinary tumor and nearby lymph nodes. It’s for people with locally advanced urothelial cancer whose cancer has at least not worsened after initial chemotherapy.
This trial tests two drugs, enfortumab vedotin and pembrolizumab, given before surgery to remove the bladder or ureter in people with advanced bladder or upper urinary tract cancer that has spread to lymph nodes or other organs. The goal is to see if this treatment helps shrink the cancer and improves outcomes.
This trial tests whether adding targeted radiation to standard drug therapy can help people with a limited number of bladder or urinary tract cancer metastases. It's for those whose cancer has spread to a few spots that can be treated with full coverage radiation.
This trial studies giving toripalimab (an immunotherapy) together with gemcitabine and cisplatin before bladder surgery. It aims to shrink locally advanced bladder cancer and make surgery more effective by using the immune system and chemotherapy together.
This trial tests a combination of two drugs (eribulin and toripalimab) given before surgery to remove bladder cancer. The goal is to shrink the tumor and improve outcomes for people with advanced or high-risk bladder cancer.
Hear when a new Locally Advanced Urothelial Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.